These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 17690869)

  • 21. Normal brain tissue volumes after long-term recovery in anorexia and bulimia nervosa.
    Wagner A; Greer P; Bailer UF; Frank GK; Henry SE; Putnam K; Meltzer CC; Ziolko SK; Hoge J; McConaha C; Kaye WH
    Biol Psychiatry; 2006 Feb; 59(3):291-3. PubMed ID: 16139807
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reported childhood abuse is associated with low serotonin transporter binding in vivo in major depressive disorder.
    Miller JM; Kinnally EL; Ogden RT; Oquendo MA; Mann JJ; Parsey RV
    Synapse; 2009 Jul; 63(7):565-73. PubMed ID: 19288578
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alterations in serotonin transporter and body image-related cognition in anorexia nervosa.
    Yokokura M; Terada T; Bunai T; Nakaizumi K; Kato Y; Yoshikawa E; Futatsubashi M; Suzuki K; Yamasue H; Ouchi Y
    Neuroimage Clin; 2019; 23():101928. PubMed ID: 31491815
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regional cerebral blood flow after recovery from anorexia or bulimia nervosa.
    Frank GK; Bailer UF; Meltzer CC; Price JC; Mathis CA; Wagner A; Becker C; Kaye WH
    Int J Eat Disord; 2007 Sep; 40(6):488-92. PubMed ID: 17525951
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vivo detection of short- and long-term MDMA neurotoxicity--a positron emission tomography study in the living baboon brain.
    Scheffel U; Szabo Z; Mathews WB; Finley PA; Dannals RF; Ravert HT; Szabo K; Yuan J; Ricaurte GA
    Synapse; 1998 Jun; 29(2):183-92. PubMed ID: 9593108
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relationship of the serotonin transporter gene promoter polymorphism (5-HTTLPR) genotype and serotonin transporter binding to neural processing of negative emotional stimuli.
    Schneck N; Miller JM; Delorenzo C; Kikuchi T; Sublette ME; Oquendo MA; Mann JJ; Parsey RV
    J Affect Disord; 2016 Jan; 190():494-498. PubMed ID: 26561939
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A PET study on regional coexpression of 5-HT1A receptors and 5-HTT in the human brain.
    Lundberg J; Borg J; Halldin C; Farde L
    Psychopharmacology (Berl); 2007 Dec; 195(3):425-33. PubMed ID: 17874074
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vivo quantification of brain serotonin transporters in humans using [11C]McN 5652.
    Parsey RV; Kegeles LS; Hwang DR; Simpson N; Abi-Dargham A; Mawlawi O; Slifstein M; Van Heertum RL; Mann JJ; Laruelle M
    J Nucl Med; 2000 Sep; 41(9):1465-77. PubMed ID: 10994724
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CSF oxytocin and vasopressin levels after recovery from bulimia nervosa and anorexia nervosa, bulimic subtype.
    Frank GK; Kaye WH; Altemus M; Greeno CG
    Biol Psychiatry; 2000 Aug; 48(4):315-8. PubMed ID: 10960163
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Temperament, character and serotonin activity in the human brain: a positron emission tomography study based on a general population cohort.
    Tuominen L; Salo J; Hirvonen J; Någren K; Laine P; Melartin T; Isometsä E; Viikari J; Cloninger CR; Raitakari O; Hietala J; Keltikangas-Järvinen L
    Psychol Med; 2013 Apr; 43(4):881-94. PubMed ID: 22850434
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High-fat taste challenge reveals altered striatal response in women recovered from bulimia nervosa: A pilot study.
    Radeloff D; Willmann K; Otto L; Lindner M; Putnam K; Leeuwen SV; Kaye WH; Poustka F; Wagner A
    World J Biol Psychiatry; 2014 May; 15(4):307-16. PubMed ID: 22540408
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Altered serotonin 2A receptor activity in women who have recovered from bulimia nervosa.
    Kaye WH; Frank GK; Meltzer CC; Price JC; McConaha CW; Crossan PJ; Klump KL; Rhodes L
    Am J Psychiatry; 2001 Jul; 158(7):1152-5. PubMed ID: 11431241
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of serum BDNF levels on central serotonin transporter availability in obese versus non-obese adults: A [(11)C]DASB positron emission tomography study.
    Hinderberger P; Rullmann M; Drabe M; Luthardt J; Becker GA; Blüher M; Regenthal R; Sabri O; Hesse S
    Neuropharmacology; 2016 Nov; 110(Pt A):530-536. PubMed ID: 27108933
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Brain type 1 cannabinoid receptor availability in patients with anorexia and bulimia nervosa.
    Gérard N; Pieters G; Goffin K; Bormans G; Van Laere K
    Biol Psychiatry; 2011 Oct; 70(8):777-784. PubMed ID: 21718968
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Eating disorders: Do PET and SPECT have a role? A systematic review of the literature.
    Gianni AD; De Donatis D; Valente S; De Ronchi D; Atti AR
    Psychiatry Res Neuroimaging; 2020 Jun; 300():111065. PubMed ID: 32234640
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quantitative positron emission tomography studies of the serotonin transporter in humans previously treated with the appetite suppressants fenfluramine or dexfenfluramine.
    McCann UD; Szabo Z; Vranesic M; Seckin E; Wand G; Duval A; Dannals RF; Ricaurte GA
    Mol Imaging Biol; 2007; 9(3):151-7. PubMed ID: 17473958
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Polymorphisms in serotonergic genes and psychopathological traits in eating disorders.
    Gervasini G; Gordillo I; Garcia-Herraiz A; Flores I; Jiménez M; Monge M; Carrillo JA
    J Clin Psychopharmacol; 2012 Jun; 32(3):426-8. PubMed ID: 22561477
    [No Abstract]   [Full Text] [Related]  

  • 38. Altered dopamine activity after recovery from restricting-type anorexia nervosa.
    Kaye WH; Frank GK; McConaha C
    Neuropsychopharmacology; 1999 Oct; 21(4):503-6. PubMed ID: 10481833
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vivo quantification of serotonin transporters using [(11)C]DASB and positron emission tomography in humans: modeling considerations.
    Ogden RT; Ojha A; Erlandsson K; Oquendo MA; Mann JJ; Parsey RV
    J Cereb Blood Flow Metab; 2007 Jan; 27(1):205-17. PubMed ID: 16736050
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quantification of serotonin transporter availability with [11C]MADAM--a comparison between the ECAT HRRT and HR systems.
    Schain M; Tóth M; Cselényi Z; Stenkrona P; Halldin C; Farde L; Varrone A
    Neuroimage; 2012 Mar; 60(1):800-7. PubMed ID: 22227138
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.